MYO Stock Forecast 2025-2026
Distance to MYO Price Targets
MYO Price Momentum
🤔 Considering Myomo (MYO)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Latest MYO Stock Price Targets & Analyst Predictions
Based on our analysis of 6 Wall Street analysts, MYO has a bullish consensus with a median price target of $9.00 (ranging from $6.75 to $11.00). The overall analyst rating is Strong Buy (9.2/10). Currently trading at $5.19, the median forecast implies a 73.4% upside. This outlook is supported by 5 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Craig Knickerbocker at Craig-Hallum, projecting a 111.9% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MYO Analyst Ratings
MYO Price Target Range
Latest MYO Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MYO.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 12, 2025 | HC Wainwright & Co. | Sean Lee | Buy | Maintains | $9.50 |
| Mar 11, 2025 | Craig-Hallum | Craig Knickerbocker | Buy | Maintains | $11.00 |
| Dec 13, 2024 | Craig-Hallum | Craig Knickerbocker | Buy | Maintains | $9.00 |
| Nov 13, 2024 | HC Wainwright & Co. | Sean Lee | Buy | Reiterates | $7.50 |
| Nov 12, 2024 | Ascendiant Capital | Edward Woo | Buy | Maintains | $9.00 |
| Aug 19, 2024 | Ascendiant Capital | Edward Woo | Buy | Maintains | $8.50 |
| Aug 12, 2024 | HC Wainwright & Co. | Sean Lee | Buy | Maintains | $7.50 |
| Jul 31, 2024 | Craig-Hallum | Craig Knickerbocker | Buy | Initiates | $7.00 |
| Jul 9, 2024 | Lake Street | Ben Haynor | Buy | Maintains | $7.50 |
| May 9, 2024 | HC Wainwright & Co. | Sean Lee | Buy | Reiterates | $6.50 |
| Dec 15, 2023 | HC Wainwright & Co. | Sean Lee | Buy | Initiates | $6.50 |
| May 25, 2023 | Maxim Group | Anthony Vendetti | Buy | Initiates | $2.00 |
| Jul 8, 2022 | Alliance Global Partners | Ben Haynor | Buy | Maintains | $6.70 |
| Sep 16, 2020 | Colliers Securities | Buy | Maintains | $8.00 |
Myomo Inc. (MYO) Competitors
The following stocks are similar to Myomo based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Myomo Inc. (MYO) Financial Data
Myomo Inc. has a market capitalization of $177.75M with a P/E ratio of -32.4x. The company generates $25.24M in trailing twelve-month revenue with a -33.2% profit margin.
Revenue growth is +81.3% quarter-over-quarter, while maintaining an operating margin of -10.4% and return on equity of -82.5%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Myomo Inc. (MYO) Business Model
About Myomo Inc.
Develops powered brace systems for mobility enhancement.
Myomo Inc. generates revenue by designing and manufacturing powered brace systems, specifically the MyoPro, aimed at assisting individuals with neuromuscular issues. The company operates within the rehabilitation sector, focusing on providing non-invasive solutions that help patients regain mobility and independence, thus catering to a growing market need.
Myomo's innovative products leverage advanced sensor technology to enhance user experience and effectiveness. The company's role in transforming rehabilitation options makes it a key player in the medical device industry, particularly in prosthetics and orthotics.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
101
CEO
Mr. Paul R. Gudonis
Country
United States
IPO Year
2015
Website
myomo.comMyomo Inc. (MYO) Latest News & Analysis
Myomo, Inc. (NYSE:MYO) will hold its Q4 2024 earnings conference call on March 10, 2025, at 4:30 PM ET, featuring key executives and analysts.
The scheduled earnings call for Myomo, Inc. signals upcoming insights into financial performance and strategic direction, impacting stock valuation and investor sentiment.
Myomo, Inc. reported Q4 2024 financial results, highlighting its focus on wearable medical robotics for neurological disorders and upper-limb paralysis. Full details will follow in the report.
Myomo's financial results indicate performance trends that could affect stock valuation and investor sentiment, particularly regarding growth in the medical robotics sector.
Myomo, Inc. (MYO) reported a quarterly loss of $0.01 per share, better than the expected loss of $0.02, improving from a loss of $0.07 per share a year ago.
Myomo's smaller-than-expected loss suggests improving financial performance, potentially boosting investor confidence and impacting stock valuation positively.
Myomo, Inc. (NYSE: MYO) will report Q4 and 2024 financial results on March 10, 2025, and host a conference call at 4:30 p.m. ET.
Myomo's upcoming financial results and conference call could impact stock performance, providing insights into growth and financial health, especially in the medical robotics sector.
The robotics industry is expanding beyond manufacturing, driven by AI and automation, with an expected CAGR of over 15%, reaching nearly $170 billion by 2032.
The rapid expansion of robotics into diverse sectors, driven by AI advancements, signals significant growth potential, projected at over 15% CAGR, indicating lucrative investment opportunities ahead.
Top 3 Cutting-Edge Micro-Caps Set for 2025 Growth
2 months agoPromising micro-cap stocks are gaining attention as 2025 approaches, with potential to disrupt industries through innovative technologies and strategic advancements.
Promising micro-cap stocks may offer high growth potential, attracting investors seeking early opportunities in disruptive technologies before mainstream adoption.
Frequently Asked Questions About MYO Stock
What is Myomo Inc.'s (MYO) stock forecast for 2025?
Based on our analysis of 6 Wall Street analysts, Myomo Inc. (MYO) has a median price target of $9.00. The highest price target is $11.00 and the lowest is $6.75.
Is MYO stock a good investment in 2025?
According to current analyst ratings, MYO has 5 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $5.19. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MYO stock?
Wall Street analysts predict MYO stock could reach $9.00 in the next 12 months. This represents a 73.4% increase from the current price of $5.19. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Myomo Inc.'s business model?
Myomo Inc. generates revenue by designing and manufacturing powered brace systems, specifically the MyoPro, aimed at assisting individuals with neuromuscular issues. The company operates within the rehabilitation sector, focusing on providing non-invasive solutions that help patients regain mobility and independence, thus catering to a growing market need.
What is the highest forecasted price for MYO Myomo Inc.?
The highest price target for MYO is $11.00 from Craig Knickerbocker at Craig-Hallum, which represents a 111.9% increase from the current price of $5.19.
What is the lowest forecasted price for MYO Myomo Inc.?
The lowest price target for MYO is $6.75 from at , which represents a 30.1% increase from the current price of $5.19.
What is the overall MYO consensus from analysts for Myomo Inc.?
The overall analyst consensus for MYO is bullish. Out of 6 Wall Street analysts, 5 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $9.00.
How accurate are MYO stock price projections?
Stock price projections, including those for Myomo Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
